Microscopic photo of an eye

Award Program Details

Program Description

Up to 3 Gund-Harrington Scholars are chosen each year. The award includes:

  • Milestone-driven payments totaling up to $900,000 over three years
  • Drug development expertise and project management support through the Harrington Discovery Institute Innovation Support Center
  • Consulting services from highly experienced drug development personnel
  • Business and commercialization advice
  • Clinical development advice
  • Regulatory assistance
  • Intellectual property review and advice
  • Assistance identifying and securing additional financial support based on project needs

The Harrington Discovery Institute and its Innovation Support Center team will work closely with the awardee and their affiliated institution to maximize the clinical and commercial potential of the selected project.

What We Fund

The Gund-Harrington Scholar Award selection committee seeks breakthrough discovery defined by innovation, creativity and potential clinical impact, including:

  • Discoveries deemed to address unmet medical needs
  • Modulators of novel targets
  • Potential to be developed into a commercial program
  • Possess strong intellectual property (IP) or protection strategy
  • May be either a small molecule, biologic, or other therapeutic modality
  • Diagnostics or devices only acceptable as part of a therapeutic development project or if completely transformative
  • Treatment strategies that are not gene specific, but might be broadly applicable across many patients
  • Therapies that may be effective in later stages of disease
  • Gene modifying or gene therapy strategies
  • Therapies that address juvenile macular degeneration
  • Regenerative medicine therapies that focus on stem cells differentiated into photoreceptor cells
  • Innovative science potentially leading to treatment or prevention of inherited retinal degenerative disease

Eligibility Criteria

To be eligible for the award, an applicant must meet the following requirements:

  • Hold an MD and/or PhD (or equivalent) and demonstrate exceptional promise
  • Hold a faculty position at an accredited academic medical center, university or research institution in the US and Canada, and conduct the majority of his/her research activities at that institution
  • A project may have only a single PI, who is responsible for project oversight and financial management. The PI may engage collaborators, core labs or commercial CROs to execute any fraction of the project.
  • Past recipients of Harrington Scholar-Innovator awards may submit new and distinct proposals, but may not seek additional support for previously funded projects.

Late submissions will not be accepted for any reason, other than issues with the Harrington Discovery Institute's submission system. Proposals received by HDI after the deadline will not be reviewed.

Questions

Any questions should be directed to HDIQuestions@HarringtonDiscovery.org.

The Harrington Project for Discovery & Development

Discover
Advance
Commercialize
Breakthrough Medicine